|
π
|
Biomarkers of aging
125 auth.
H. BαΊ£o,
Jiani Cao,
Mengting Chen,
Min Chen,
Wei Chen,
Xiao Chen,
Yanhao Chen,
Yu Chen,
Yutian Chen,
Zhiyang Chen,
J. K. Chhetri,
Yingjie Ding,
Junlin Feng,
Jun Guo,
Mengmeng Guo,
...
Chuting He,
Yujuan Jia,
Haiping Jiang,
Ying Jing,
Dingfeng Li,
Jiaming Li,
Jingyi Li,
Qinhao Liang,
Rui Liang,
Feng Liu,
Xiaoqian Liu,
Zuojun Liu,
Oscar Junhong Luo,
Jianwei Lv,
Jingyi Ma,
Kehang Mao,
Jiawei Nie,
Xinhua Qiao,
Xinpei Sun,
Xiaoqiang Tang,
Jianfang Wang,
Qiaoran Wang,
Siyuan Wang,
Xuan Wang,
Yaning Wang,
Yuhan Wang,
Rimo Wu,
Kai Xia,
Fu-Hui Xiao,
Lingyan Xu,
Yingying Xu,
Haoteng Yan,
Liang Yang,
Ruici Yang,
Yuanxin Yang,
Yilin Ying,
Le Zhang,
Weiwei Zhang,
Wenwan Zhang,
Xing Zhang,
Zhuo Zhang,
Min Zhou,
Rui Zhou,
Qingchen Zhu,
Zhengmao Zhu,
F. Cao,
Zhongwei Cao,
P. Chan,
Chang Chen,
Guobing Chen,
Houzao Chen,
Jun Chen,
W. Ci,
Bisen Ding,
Q. Ding,
Feng Gao,
Jiawei Han,
Kai Huang,
Z. Ju,
Q. Kong,
Ji Li,
Jian Li,
X. Li,
Baohua Liu,
Feng Liu,
Lin Liu,
Qiang Liu,
Qiang Liu,
Xingguo Liu,
Yong Liu,
Xianghang Luo,
Shuai Ma,
Xinran Ma,
Zhi-Chao Mao,
Jing Nie,
Yaojin Peng,
J. Qu,
Jie Ren,
R. Ren,
Moshi Song,
Z. Songyang,
Y. E. Sun,
Yu Sun,
Mei Tian,
Shusen Wang,
Si Wang,
Xia Wang,
Xiaoning Wang,
Yanjiang Wang,
Yunfang Wang,
Catherine C. L. Wong,
A. Xiang,
Yichuan Xiao,
Zhengwei Xie,
Daichao Xu,
Jing Ye,
Rui Yue,
Cun-yuan Zhang,
Hongbo Zhang,
Liang Zhang,
Weiqi Zhang,
Yong Zhang,
Yun-wu Zhang,
Zhuohua Zhang,
T. Zhao,
Yuzheng Zhao,
Dahai Zhu,
Weiguo Zou,
Gang Pei,
Guangyan Liu
|
7 |
2023 |
7
π
|
|
π
|
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
13 auth.
Mengmeng Ji,
Yao-hui Huang,
Jin-Yan Huang,
Zhao Wang,
D. Fu,
Feng Liu,
C. Leboeuf,
Li Wang,
Jing Ye,
Yi-ming Lu,
...
A. Janin,
Shu Cheng,
Weili Zhao
|
6 |
2018 |
6
π
|
|
π
|
A novel prognostic model based on four circulating miRNA in diffuse large Bβcell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression
12 auth.
Rui Sun,
Zhong Zheng,
Li Wang,
Shu Cheng,
Q. Shi,
B. Qu,
...
D. Fu,
C. Leboeuf,
Yan Zhao,
Jing Ye,
A. Janin,
Weili Zhao
|
4 |
2020 |
4
π
|
|
π
|
Clinical efficacy and tumour microenvironment influence of decitabine plus RβCHOP in patients with newly diagnosed diffuse large BβCell lymphoma: Phase 1/2 and biomarker study
20 auth.
Muchen Zhang,
Ying Fang,
P. Xu,
Lei Dong,
R. Shen,
Yao-hui Huang,
D. Fu,
Zi-xun Yan,
Shu Cheng,
Xu-feng Jiang,
...
Q. Song,
Yang He,
Yan Zhao,
Min Lu,
Jing Ye,
Feng Liu,
Lin Cheng,
Chao-Fu Wang,
Li Wang,
Weili Zhao
|
3 |
2021 |
3
π
|
|
π
|
Apatinib enhances chemosensitivity of ABTβ199 in diffuse large Bβcell lymphoma
8 auth.
Yuanfei Shi,
Jing Ye,
Huafei Shen,
Yi Xu,
Rui Wan,
X. Ye,
...
Jie Jin,
W. Xie
|
2 |
2022 |
2
π
|
|
π
|
Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma
15 auth.
Yiwen Cao,
Zhenhua Liu,
Wen Wu,
Ying Qian,
Q. Shi,
R. Shen,
B. Ouyang,
P. Xu,
Shu Cheng,
Jing Ye,
...
Yi-ming Lu,
Chaofu Wang,
Chengde Yang,
Li Wang,
Weili Zhao
|
1 |
2019 |
1
π
|
|
π
|
A Novel Circulating 4-miRNA Prognostic Model in Diffuse Large B-Cell Lymphoma: Role of MDSCs and Th17 Cells on Lymphoma Progression
12 auth.
Rui Sun,
Zhong Zheng,
Li Wang,
Shu Cheng,
Q. Shi,
B. Qu,
...
D. Fu,
C. Leboeuf,
Yan Zhao,
Jing Ye,
A. Janin,
Weili Zhao
|
0 |
2020 |
0
π
|
